Nuremberg, Germany

Ingomar Grafe


 

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 1987-1990

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ingomar Grafe: Innovator in Pharmaceutical Chemistry

Introduction

Ingomar Grafe is a notable inventor based in Nuremberg, Germany, recognized for his significant contributions to the field of pharmaceutical chemistry with a portfolio of four patents. His innovative approaches have advanced the preparation and application of vital chemical compounds, particularly in the treatment of health disorders.

Latest Patents

Grafe's most recent patents include a method for the preparation of 2,6-dichlorodiphenylaminoacetic acid. This invention outlines a new technique for synthesizing 2,6-dichlorodiphenylamine derivatives, achieving high yields and remarkable purity through a straightforward process. Another important patent describes stable solvent adducts related to Z-1-(p-.beta.-dimethylaminoethoxyphenyl)-1-(p-hydroxyphenyl)-2-phenyl-but-1-ene. These adducts demonstrate significant antioestrogenic activities and are positioned for therapeutic applications, particularly in treating benign breast diseases and hormone-dependent mammary tumors via percutaneous methods.

Career Highlights

Throughout his career, Ingomar Grafe has been affiliated with prominent companies in the pharmaceutical sector, such as Heumann Pharma GmbH & Co. and Ludwig Heumann & Co. GmbH. His work in these organizations has facilitated the development of innovative solutions for the healthcare industry, highlighting his expertise and dedication to pharmaceutical advancements.

Collaborations

During his career, Grafe has collaborated with esteemed colleagues, including Kurt H. Ahrens and Helmut Schickaneder. These partnerships have contributed to his successful innovations, combining their knowledge to advance methodologies in pharmaceutical research and development.

Conclusion

Ingomar Grafe's contributions to the field of pharmaceutical chemistry exemplify the impact of innovation in healthcare. Through his inventions, he has paved the way for new treatments and solutions for significant medical challenges. His ongoing commitment to research and development solidifies his legacy as a distinguished inventor in the pharmaceutical domain.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…